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Live monitoring of cellular metabolism and
mitochondrial respiration in 3D cell culture system
using NMR spectroscopy†
Damian Hertig, a,b,c Sally Maddah,a,b Roman Memedovski,a,b Sandra Kurth,b
Aitor Moreno,d Matteo Pennestri,e Andrea Felser,b Jean-Marc Nuoffer*‡b,f and
Peter Vermathen *‡a
Background: Because of the interplay between mitochondrial respiration and cellular metabolism, the
simultaneous monitoring of both cellular processes provides important insights for the understanding of
biological processes. NMR flow systems provide a unique window into the metabolome of cultured cells.
Simplified bioreactor construction based on commercially available flow systems increase the practicabil-
ity and reproducibility of bioreactor studies using standard NMR spectrometers. We therefore aim at
establishing a reproducible NMR bioreactor system for metabolic 1H-NMR investigations of small mole-
cules and concurrent oxygenation determination by 19F-NMR, with in depth description and validation by
accompanying measures. Methods: We demonstrate a detailed and standardized workflow for the prepa-
ration and transfer of collagen based 3D cell culture of high cell density for perfused investigation in a
5 mm NMR tube. Self-constructed gas mixing station enables 5% CO2 atmosphere for physiological pH in
carbon based medium and is perfused by HPLC pump. Results & Discussion: Implemented perfused bio-
reactor allows detection of perfusion rate dependent metabolite content. We show interleaved dynamic
profiling of 26 metabolites and mitochondrial respiration. During constant perfusion, sequential injection
of rotenone/oligomycin and 2-deoxy-glucose indicated immediate activation and deactivation of glyco-
lytic rate and full inhibition of oxygen consumption. We show sensitivity to detect substrate degradation
rates of major mitochondrial fuel pathways and were able to simultaneously measure cellular oxygen
consumption.
Introduction
The mitochondrion is an organelle found in nearly all eukary-
otic cells and is the main source of energy production. It
serves as prime site of adaptation to nutrient availability and
energy production with the stepwise catabolism of fuelled
monosaccharides, fatty acids and amino acids from the
cytosol.1 It is well known that the role of mitochondria in cell
biology goes beyond ATP production through oxidative
phosphorylation.2,3 Multiple metabolic signalling pathways
have been described including release of mitochondrial
metabolites, modulation of calcium fluxes or production of
free radicals.4,5 Empirically most common outcomes of in vitro
toxicity screening are mitochondrial perturbations.6 This high-
lights the need for methods enabling simultaneous obser-
vation of cellular metabolic profiles and mitochondrial oxi-
dative function to better understand interplay and investigate
patho-mechanisms. Numerous studies demonstrate strong
interdependence of observed cellular metabolite content and
energetic state.7–9 While most current in vitro monitoring
methods detect individual metabolites or mitochondrial
activity there are increasing efforts in detecting multiple
metabolites in cell cultures.10
Metabolic investigation of living cells using NMR spectroscopy
High resolution NMR has been established as a powerful tool
for metabolic characterization of cells, extracts, biopsies or
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organisms.11–20 However, analysis of cell lysates or extracts
renders longitudinal metabolic studies investigating response to
challenges laborious, as repeated sample preparation is needed.
Further the variability between the biological samples related to
cell manipulation needs to be considered, when investigating
cells longitudinally or upon intervention. The investigation of
rapidly changing metabolic cell responses are challenging and
require very efficient quenching of metabolism.
These obstacles can be addressed by NMR measurements
of intact cells in their “natural” environment, i.e. cell culture
in presence of complete enzymatic and regulatory systems.21
However, this requires maintaining viable cell culture con-
ditions with optimized parameters.22 Perfused cell and organ
model systems for NMR have been developed already in the
1980s and 1990s for the investigation of biochemistry and
physiology.23–27 These perfused cell and organ studies require
a perfusion apparatus controlling nutrient delivery, tempera-
ture, pH, and gas delivery to keep cells close to natural
conditions.
Only few systems employ standard 5 mm NMR tubes appli-
cable for the most widespread standard 5 mm NMR
probes.28–31 In order to increase the volume in the NMR sensi-
tive region most use wide-bore probes (≥10 mm)32–36 which
are however not routinely available at most centers.
Furthermore, the disadvantage of the much lower filling
volume is partly compensated by the higher filling factor of
the smaller radio frequency coil. Other advantages of smaller
volumes include easier nutrition and oxygen delivery to the
cells, a more direct response of the smaller volume upon chal-
lenges due to faster medium exchange, and lower material
costs of chemicals facilitating approaches of in vitro drug or
toxicity screening.37,38 Other very interesting and elegant
recent efforts involve microfluidic devices for 1H NMR metabo-
lomic investigations with lab-on-a chip technology of cell cul-
tures like single tumor spheroids.39,40 While very promising,
these systems pose several technical and scientific challenges
and are also not readily available. Furthermore, in cases where
the number of available cells is of no concern, miniaturization
may not be required. Very recently Bruker released a flow tube
(InsightMR™, Bruker), which allows for online reaction moni-
toring41 and its further specialization InsightCell™. The
InsightCell™ flow tube is compatible with standard 5 mm
NMR probes, i.e. no special probe is required. The implemen-
tation is presented here.
The vast majority of NMR investigations on living cells in
bioreactors have applied 31P NMR to investigate metabolism or
13C NMR of labelled (hyperpolarized) substrates, in order to
trace metabolic pathways in real time and measure metabolic
fluxes.42,43 Only few studies performed 1H NMR investigations
for small metabolite detection25,29,30,39,44–48 and even less
longitudinal 1H NMR metabolomical investigations of living
cell cultures in bioreactors under controlled cell culture con-
ditions. Besides assessment of metabolic changes, determi-
nation of oxygenation and oxygen consumption is highly valu-
able as a surrogate marker of aerobic energy production via
mitochondrial oxidative phosphorylation.
Various non-NMR based approaches for oxygen consump-
tion studies investigation have been established, such as
oxygen measurement using amperometric oxygen sensors49–51
or optical sensors.52 Although these techniques provide
detailed information on the oxygen consumption of cells,
none of these methods provide data on the metabolome and
do therefore not allow for studying interaction of mitochon-
drial function and metabolome.
Oxygen quantification in living cell culture using 19F NMR
In our approach, the provided oxygen content is quantified
within perfused solid phase 3D cell cultures, using embedded
fluorine atoms. We hypothesize that this in situ measurement
enables detection of unwanted local hypoxia and facilitates
setting a desired oxygen content inside the scaffold, rather
than in systems placing the oxygen sensor outside solid phase
3D cell cultures.
NMR based approaches for measuring oxygen content by
detection of oxygen dependent T1 spin–lattice relaxation times
of perfluorinated compounds, have been described
frequently.53–55 These approaches mainly focus on long-term
tissue or cell oxygenation or the investigation of oxygen con-
sumption in cells or organisms cultured in suspension. One
study performed real-time measurements of oxygen tension in
two layers of perfluorotripropylamine-doped alginate beads
placed before and after perfused cancer cells on microbeads.35
To our knowledge, no NMR-based protocol has been
described which quantified oxygen concentration with high
temporal resolution inside perfused solid phase based 3D cell
cultures.
Human fibroblasts as 3D cell culture model
Fibroblasts are easy to cultivate, widely used in biochemical,
genetic and toxicological studies, and can provide a model to
study specific disease states or normal physiology.56,57
Fibroblast-collagen matrix cultures enable the analysis of cell
physiology under conditions that more closely resemble an
in vivo-like environment than conventional 2D cell culture.58
Therefore, collagen based 3D fibroblast cultures were used as
cell culture model in this bioreactor study.
Aim
To our knowledge, no study has been performed on living
human 3D cell culture in a standard 5 mm NMR probe system
that combined the measurement of metabolic profiles by 1H
NMR with measurements of oxygen consumption using 19F
NMR with a time resolution of a few minutes. The aims of this
study are therefore (1.) to investigate the cell embedding strat-
egies and analyze the viability of the cells, (2.) to establish the
perfused NMR bioreactor using the InsightCell™ flow tube
with a standard 5 mm NMR probe, (3.) to test the detectability,
stability and reproducibility of longitudinal and fast dynamic
metabolic processes (4.) to test the sensitivity of 19F T1 relax-
ation based oxygen quantification as surrogate marker of mito-
chondrial oxidative phosphorylation in order to perform com-
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bined metabolic measurements and (5.) to test sensitivity to
pathway changes upon pathway-specific inhibitors.
Materials & methods
Conventional 2D cell culture
Human fibroblasts (anonymous cell lines) were previously
established from skin biopsy from healthy controls in routine
diagnostics and kindly provided form the routine cell culture
laboratory of the Centre of Laboratory Medicine of the
University Hospital Bern. The control fibroblast cell line was
cultured in minimal essential medium (MEM) supplemented
with 10% fetal calf serum, 1× non-essential amino acids
(100 µM glycine, L-alanine, L-asparagine, L-aspartic acid,
L-glutamic acid, L-proline, L-serine) (GIBCO/Invitrogen,
Carlsbad, CA), 2 mM L-glutamine, 200 μM uridine, 1 mM
sodium pyruvate, 100 U ml−1 penicillin, and 100 μg ml−1 strep-
tomycin and 10 μg ml−1 chlortetracycline at 37 °C and 5%
CO2. The medium was exchanged between two and three times
a week. Fibroblasts were cultured at 37 °C in a humidified 5%
CO2 cell culture incubator and were passaged using 0.05%
trypsin–EDTA. Cell numbers were determined in a Neubauer
hemacytometer using trypan blue exclusion method.
3D cell culture preparation
Based on previous NMR studies, a minimum of five million
fibroblasts were estimated to provide sufficient signal to
perform proton-based metabolic analyses within few minutes
of acquisition.59 Therefore we evaluated a range of cell number
from five million cells up to twenty million.
Embedding procedure. Collagen based membrane matrices
(Cultrex™ RGF BME Type R1) were diluted to final protein con-
centration of 5–7 mg ml−1. All fibroblasts were transferred into
collagen based membrane matrix and polymerized at 37 °C for
30 minutes inside sterile infusion tube (Volumed®-Set
Silicone) as shown in Fig. 1. After polymerization of the
matrix, the scaffold containing the cells was softly released
into a Petri dish containing 35 ml medium for incubation up
to 7 days. The medium was exchanged daily.
Viability and metabolic activity in 3D culture. Glucose con-
sumption and lactate production were measured in the super-
natant after each 24 hours using cobas® b 123 POC system
(Roche). LDH activity in the supernatant was measured daily
using Roche diagnostics cobas 8000 analyzer to exclude cytoly-
sis. Light microscopic data were used to observe stability of the
scaffold volumes and to investigate morphology of the 3D cell
culture up to seven days. For each bioreactor experiment the
corresponding number of replicas is given in the results
section.
Preparation of PFTBA carrier. 40 mg dry Cytodex 1 microcar-
rier beads were shaken with 3 × 3 mm metal balls at 20 Hz for
5 minutes and broken into smaller fragments. In one approach
40 mg of crushed Cytodex 1 beads and in a second approach a
15 cm long and 0.27 mm thick cotton thread were incubated
for 24 hours in 500 µl pure PFTBA in order to absorb the
fluorinated substance. Subsequently both carriers were washed
in 5 steps with PBS and subsequently embedded inside
cultrex™ RGF BME Type R1 based scaffold.
Some of the preliminary test measurements were performed
with emulsified PFTBA. 0.18% (vol/vol) of PFTBA emulsified
with lecithin was added to Tyrode buffer containing 5% D2O
pH 7.4.60
Fig. 1 (1.) Up to 20 million primary human fibroblasts were cultured in
2D monolayers. (2.) A sterile infusion tube with an inner diameter of
4.2 mm (A) was attached to the tip of a conventional pipette (B), allowing
transport of the cell suspension between the Petri dish (C) and the
5 mm NMR tube (D). (3.) Harvested cells were resuspended in liquid cell-
collagen (cultrex™) suspension and injected into the sterile infusion
tube. (4.) The open ends of the sterile infusion tube were sealed inside a
sterile Falcon tube. The sterile infusion tube was subsequently placed in
a water bath at 37 °C for 30 minutes. This allowed rapid polymerization
of the cultrex™ under sterile conditions. (5.) After 30 minutes, the poly-
merized scaffold was released into a Petri dish using the air pressure of a
connected pipette. (6.) Daily monitored cell morphology using light
microscopy (7), glycolytic activity as well as LDH release (see Fig. 2) were
performed to control for high viability of the 3D cell culture sample
under normal culture condition in a CO2 incubator. (8.) For all NMR
experiments the scaffold was taken up using an infusion tube and
inserted into the standard 5 mm NMR tube after 2 days embedment in
collagen. LDH measurement revealed no mechanically induced cell
death after loading the 3D scaffold into the NMR tube. (9.) The filled
standard NMR tube was connected to the InsightCell™ perfusion device
and inserted into the NMR spectrometer within few minutes.
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NMR experiments were carried out on a 500 MHz Bruker
Avance II spectrometer. HR-liquid state NMR experiments of
cell culture samples were performed with a 5 mm ATM BBFO
probe with z-gradient. The bioreactor was perfused using the
same cell culture medium as described above for 2D cell
culture but additionally supplemented with 5% D2O. For
experiments with chemical inhibitors (glycolytic stress test),
no fetal calf serum was added to the perfused medium to
prevent possible binding of serum albumin with drugs used.
Mitochondrial function was inhibited by combined addition
of rotenone 5 µM (CI inhibitor) and oligomycin 5 µM
(Inhibitor of mitochondrial phosphorylation). Competitive gly-
colysis inhibitor 2-deoxy-D-glucose (5 mM) was used for glycoly-
sis inhibition.
Perfusion apparatus & gas mixing station. HPLC pumping
system (Agilent) was used for constant perfusion of substrate
via the perfusion apparatus using the flowtube unit. The flow
tube has a capacity of 0.5 ml and is compatible with standard
Bruker 5 mm probes, i.e. no special probe is required. For
temperature control, water at 37.5 °C was pumped through a
separate loop within the perfusion apparatus for coating the
perfused medium. The NMR probe temperature inside the
NMR magnet was set to 37 °C. A self-constructed gas blend-
ing system enabled the direct bubbling of a precisely defined
gas mixture of N2, O2 and CO2 into the external substrate
bottle before perfusion. For all experiments, an atmospheric
composition of 5% CO2 was used to stabilize the physiologi-
cal pH of 7.4 using carbon based buffer system. In experi-
ments with flow rate reduction (<0.2 ml min−1), higher per-
fused oxygen level of 45% was selected compared to (stan-
dard) 21% O2 in the glycolytic stress test experiments with
constant high perfusion of 0.2 ml min−1. The higher O2 level
increases the percentage of available oxygen during the stop
phases and delays the generation of hypoxic conditions. Gas
flow rates were regulated by DigiFlow™ digital flowmeters
(Draeger Medical).
1H NMR for metabolic analysis. Each 1H NMR spectrum was
acquired using the 1D PROJECT61 pulse sequence with water
presaturation and a T2-filter of 80 ms. All spectra were
measured using the same parameters: a nominal temperature
of 37 °C, a spectral width of 10 000 Hz, a data size of 64 K
points, 32 or 48 transients (≈4 or 5 min), an acquisition time
of 3.28 s and a relaxation delay of 5 s. Spectral processing was
performed using the Bruker Topspin software (version 3.2,
patch level 5). The FIDs were exponentially multiplied using a
line-broadening factor of 1 Hz and Fourier transformed.
Phased and baseline corrected 1H NMR spectra were calibrated
to the left peak of the lactate –CH3 doublet (1.324 ppm).
Spectral assignments were based on literature references,62,63
our own additional 2D correlation spectroscopy (1H1H-TOCSY)
measurements and data obtained from the Human
Metabolome Database (HMDB).64 From the pre-processed
fibroblast 1H spectra spectral regions (buckets) with a variable
bucket size according to the peak width were selected and inte-
grated. In control measurements of polymerizing collagen
without cells a resonance at 3.7 ppm was measured, which
almost completely disappeared after the first 30 minutes as
polymerization progressed and was no longer detected after
overnight incubation with cells.
For chemometric analysis, the selected buckets were mean
centred an analysed using PLS_Toolbox MatLab software
(R2014b, The MathWorks Inc.). Principle Component
Analysis (PCA) were performed to compare the metabolite
content over time of fibroblast cell cultures under various
perfusion rates.
19F NMR for rapid oxygen quantification using PFTBA car-
riers. 19F spin–lattice relaxation rate measurements were per-
formed for oxygen quantification. The 19F NMR spectrum of
PFTBA was calibrated to the δ(–CF3) resonance at 83.3 ppm
(ref. 65). The carrier frequency was set to 83.3 ppm in order to
match the excitation bandwidth to the analysed PFTBA δ(–CF3)
resonance.
All measurements were performed using a pseudo 2D inver-
sion recovery 180°-τ-90° pulse sequence (t1pir) using 8 incre-
mented delay times (0.005 s, 0.646 s, 1.317 s, 2.030 s, 2.804 s,
3.676 s, 4.732 s, 6.277 s) with 4–8 scans per time increment
(total of 5–10 min). 1D spectra were manually phased and
baseline corrected. Bruker Topspin software (version 3.2, patch
level 5) was used for calculating T1 relaxation times based on I
[t] = I[0] × (1 − 2A × exp(−t/T1)).
Results & discussion
We successfully built an NMR bioreactor system using a stan-
dard 5 mm NMR tube and commercially available flowtube
apparatus. We evaluated the stability and reproducibility, opti-
mized the 3D cell preparation and show the effect of cell
number and perfusion rate on metabolism. Metabolic and
mitochondrial respiration changes upon interventions were
detected within minutes using 1H NMR for metabolite levels
and 19F NMR for detection of oxygen level in 3D cultured
human fibroblasts.
3D cell culture sample preparation
The designed protocol for fibroblast embedding in a 3D col-
lagen-based scaffold and subsequent rapid transfer into the
NMR spectrometer within a few minutes is described step by
step in Fig. 1. Five, 10, 15 and 20 million fibroblasts were
incorporated into a 3D collagen-based matrix and cultured in
standard cell culture incubator up to seven days (Fig. 1, steps 6
and 7). Documentation over a period of seven days showed a
change in volume over time depending on cell density
(Fig. 2a). Cellular contraction in collagen based matrix resulted
in a decrease of scaffold volume from 35 to 70% after cell re-
adhesion in the first 24 hours. Volume reductions declined to
an average of 7% to 11% in the following six days. Observed
contraction of collagen embedded fibroblasts as a function of
cell density and its volume stabilization after days is consistent
with the observations described in the literature.66,67
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Standardization of cell density and days of incubation in col-
lagen-based 3D cell culture before NMR experiment is there-
fore essential in order to get reproducible data in repeated
experiments.
Viability. Cell viability is an important factor for a stable
system and the above mentioned aims. Lactate dehydrogenase
(LDH) activity from cultured medium is known as sensitive
marker for determination of lysed cells as cell lysis marker.68
No significantly increased in LDH activity was found in any of
the daily collected supernatants up to seven days which
allowed exclusion of cytolysis under 3D culture condition
(Fig. 2b). Supplemented bovine serum in the medium caused
background activities of LDH < 95 U L−1. Investigations in the
course of establishing the 3D cell preparation protocol revealed
that with regard to cell lysis, external polymerization (from
steps 5 to 7 of Fig. 1) was superior to direct polymerization of
the cells in the 5 mm NMR tube, guaranteeing high cell viabi-
lity during NMR experiments (data not shown).
Glycolytic activity. Glycolytic activity was monitored detect-
ing daily glucose consumption and lactate production in cul-
tured medium. The different cell densities showed relatively
stable glycolytic activity between day 1 to 7 under 3D culture
condition (Fig. 2c). The ratio of produced lactate to consumed
glucose however increased with higher cell density. This indi-
Fig. 2 (a) The acquisition of the length and width of the cylindrical sample via light microscopy allowed the estimation of the volume of the 3D cell
culture scaffold. (b) LDH activity in cultured medium from all cell densities was measured daily. Supplemented bovine serum in the medium caused
detected background LDH activity < 95 in control samples with cell free medium + cultrex™. No significant release of LDH was observed in any of
the 3D cell culture scaffolds of 5–20 million fibroblasts during 7 days. As positive control, cells were mechanically lysed during 30 seconds using
ultrasonic bath sonicator. (c) Daily monitoring of the glucose consumption and lactate production in cultured medium over 7 days showed increased
ratio of lactate to glucose related to increasing cell density.
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cated that high cell density 3D culture influenced the cell
energy phenotype towards higher anaerobic glucose metab-
olism. A comparison of the glycolytic activity between fibro-
blasts in 2D and 3D cell cultures (results not shown in detail)
revealed an approximately two times lower glucose consump-
tion and lactate production in 3D cells (with the ratio depend-
ing in addition upon the cell density). This observation is in
agreement with detected 50% decrease of glucose uptake and
lactate secretion in fibroblasts after contact inhibition as it
happens in 3D cell culture.69 Cell density dependent differ-
ences in glycolytic activity also call for high standardization of
cell culture conditions in order to obtain reproducible results
in bioreactor studies.
Transferring cell culture sample. Based on these results, col-
lagen-based scaffolds with 20 million fibroblasts were trans-
ferred from the culture flask to the 5 mm NMR flow tube after
two days of 3D cell culture for all experiments (detailed
description in Material & methods section). The cell transfer
depicted in Fig. 1 was done by using a pipette connected to a
sterile infusion tube of 4.2 mm diameter (Fig. 1) providing
sufficient mechanical stability to transport embedded cells
without visible damage (confirmed by optical light
microscopy) or detectable cytolysis (measured via LDH release
in the sampled medium; data not shown).
Perfused NMR bioreactor experiments
A detailed scheme of the perfused NMR bioreactor is described
in Fig. 3. The carbon-based buffered glucose medium was con-
trolled for a physiological pH of 7.4 using pH meter before
perfusion.
Evaluation of cell viability in dependence on perfusion rate.
Different flow rates between 0.025 and 0.3 ml min−1 were
applied over a period of 12 hours. None of the flow rates led to
cytolysis and showed changes in LDH levels in the outflow
proofing integrity of cell membranes. A flow rate of 0.025 ml
min−1 resulted in a pH drop down to 7.0 detected in collected
medium at the outlet of the bioreactor system. No slower flow
rates than 0.025 ml min−1 were used for more than 30 min to
avoid cell death and increased ROS production at pH < 7.70 At
a perfusion rate of 0.025 ml min−1, the collected medium con-
tained the highest ratio of 1.77 for lactate production/glucose
consumption (determined using cobas®b 123; ESI Table 1†).
Lower ratios were measured for higher flow rates up to 0.3 ml
min−1. Shear forces have been described to influence prolifer-
ation rate and cell morphology (alignment) of fibroblasts.71 In
order to limit mechanical influences due to the perfusion rate,
no flow rate higher than 0.3 ml min−1 was tested in this study.
These differences in perfusion rate dependent metabolic activi-
Fig. 3 Setup of the bioreactor inside the NMR spectrometer. (a) A self-constructed gas blending system was used for mixing atmosphere compo-
sition, adjusted via different flow rates of the different gases. Before the experiment, the atmospheric composition of dissolved gas in medium was
adjusted by bubbling directly into the substrate bottle for at least five minutes. To maintain the dissolved gas mixture, a balloon with slight overpres-
sure was connected to the closed system. (b) Agilent HPLC pumping system was connected to HPLC tubes of the insightCell™ tool, which allow the
substrate transport within the water circuit of the tool. (c) Water at 37.5 °C from waterbath was pumped through the external water circuit of the
insightCell™ using subaqueous pump with a capacity of 1–5 L min−1. Temperature at the outlet of the circuit showed temperature at 36.5 °C. (d) The
substrate is delivered via an inlet at the bottom of the 5 mm NMR glass tube. The released medium diffuses through the 3D cell culture system and is
removed at the upper end of the 0.5 ml measuring volume.
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ties demonstrate that also the applied flow rate needs to be stan-
dardized and controlled for reproducible bioreactor results.
1H NMR for metabolic analysis
1H NMR spectra of embedded fibroblasts and cell medium
were obtained in the bioreactor during perfusion. Resonances
were assigned to overall 26 intra- and extracellular metabolites
under applied standard cell culture condition (Fig. 4). In order
to evaluate the sensitivity of the measurements detecting meta-
bolic changes, experiments were performed with repeatedly
changed perfusion rates for short- and long-term periods
(Fig. 5). Using all resonances assigned to metabolites, PCA was
performed for determination of overall spectral changes and
demonstration of data stability.
Short-term flow rate interruptions. In Fig. 5a, the first prin-
cipal component (PC1) of a PCA analysis is plotted versus the
measurement time and clearly showing the periodic change of
the PC with complete separation of the spectra between
stopped (∼15 min) and continuous flow and a return of PC1 to
the same level when the flow was resumed. The corresponding
loading plot (Fig. 5b) demonstrates predominantly contri-
butions from glucose, pyruvate and lactate for the periodic
changes of PC1.
Long-term flow rate changes. In another approach, flow
rates were not stopped but changed and longer time periods
(∼100 min) were used. PC1 plotted versus the measurement
time clearly shows flow rate dependent changes with complete
separation of the spectra at perfusion of 0.2, 0.05 or 0.025 ml
min−1 (Fig. 5c). The corresponding loading plot (Fig. 5d)
demonstrates strong contributions from glucose, lactate as for
the short-term flow breaks. Additionally other metabolites,
especially glutamine and alanine, which did not show strong
fast periodic adaptations to short-term interruptions contribu-
ted to PC1, i.e. adaptations of these metabolites were detect-
able after lowering the flow rate for long time periods
(>30 minutes). Individual peak analysis confirmed interven-
tion specific findings in short- and long-term flow rate
changes: metabolite content of selected energetically relevant
metabolites, i.e. glucose, pyruvate, lactate, glutamine and fatty
acids are shown in ESI Fig. S1.† No increase in LDH activity
collected in outflow was observed in all performed interven-
tion experiments.
The feasibility to measure ongoing anaerobic glycolysis of
living cells by proton NMR spectroscopy in the 5 mm flow tube
has also been demonstrated by Cerofolini et al.29 for HEK293 T
cells. We demonstrate in addition the feasibility for 1H NMR
based metabolic investigation of fibroblasts cultured under
controlled and stable conditions. Further, we show sensitivity
to repeatedly measured flow rate dependent differences in a
variety of metabolites, including glycolytic- and glutaminolytic-
related metabolites with high temporal resolution.
Importantly, metabolites returned repeatedly to the initial
level over several hours of resumed flow.
19F NMR for oxygen quantification using perfluorotributyl-
amine (PFTBA)
Obtaining cell culture oxygenation simultaneously to meta-
bolic content would allow deeper insight into dynamic meta-
bolic processes and the energetic state of cultured cells.
Oxygenation determination via 19F NMR based detection of T1
spin–lattice relaxation times was therefore implemented as
surrogate marker of mitochondrial activity detected in collagen
embedded cells.
T1 relaxation time of emulgated PFTBA. Test measurements
of emulsified PFTBA in aqueous phase 0.8% (v/v) showed the
expected correlation between 19F T1 relaxation times and
oxygen content.55 However, resonances from the emulsifier
lecithin overlapped with resonances of the cell metabolites
thus impeding the use of 1H NMR spectra. Furthermore, inter-
ference with the cell metabolism and membrane integrity
could not be excluded. Therefore, we intended development of
an approach without the use of emulsifier.
T1 relaxation time of pure PFTBA. Pure liquid PFTBA dro-
plets of total 100 µl and 250 µl were embedded in cell free col-
lagen based scaffold and perfused by medium with various
oxygen quantities. Only slow adjustments of the T1 times were
recorded (over hours). Lack of emulsifier clearly increased size
of embedded PFTBA droplets (up to ∼1 mm estimated by light
microscopy). Lower contact surface between PFTBA and
Fig. 4 Assigned regions of a representative 500 MHz 1H NMR spectrum
of 20 million fibroblasts measured during perfusion of insightCell™ at
0.2 ml min−1 for 48 acquisitions (≈5 min). In the range of applied flow
rates 0–0.2 ml min−1, the signal resolution and the shim remained rela-
tively stable and did not affect the spectral analysis of the experiments
with altered or stopped flow.
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aqueous phase might explain the delayed T1 adaptation to
oxygen level changes in PFTBA droplets. In order to avoid
larger droplets, a protocol for micro-carrier incubation in
PFTBA was developed, which retains only small amounts of
PFTBA sufficient for T1 detection.
T1 relaxation time of PFTBA carrier. Two micro carriers were
incubated in PFTBA to absorb and retain PFTBA on its surface.
Cotton thread of 0.27 mm diameter or cytodex microbeads
powder were incubated for 24 hours (detailed description in
material & methods). Prepared and washed PFTBA carriers
were polymerized into cell-free collagen-based scaffold and
perfused with medium with different quantities of dissolved
oxygen. The sensitivity of T1 relaxation times to different
oxygen concentrations is shown in a standard curve (Fig. 6a).
Using these carriers there was only few minutes delay between
oxygen level change and T1 adaptation. No carrier related
differences were observed.
Combined 1H metabolic and 19F oxygen quantification
In order to test the sensitivity for detecting changes in oxygen
tension in cell cultures upon challenges, “stop and go”
measurements were performed analogous to flow-rate inter-
ruption experiments previously described. Collagen based cell
culture scaffold with 20 million embedded fibroblasts and
PFTBA carriers were perfused under constant flow at 0.2 ml
min−1 (Fig. 6b). Alternately, 19F NMR based T1 relaxation times
for oxygen measurement as a marker of mitochondrial oxi-
dative phosphorylation and 1H NMR for measuring changes in
metabolite content were measured with an acquisition time of
6 and 4 minutes respectively. Interruption of the perfusion
rate for ∼30 minutes resulted repeatedly in a decrease of the
remaining oxygen concentration due to continuous cellular
respiration. Both, PFTBA coated thread and beads in 3D cell
culture scaffold enabled detection of adapting T1 times in
Fig. 5 Chemometric analysis. (a and c) Unsupervised principle component analysis (PCA) of all metabolite spectra acquired during short- and long-
term flow rate interventions are shown. Spectra deriving from different perfusion rates and non-perfusion were completely separated on PC1. Short-
and long-term intervention resulted distinct changes in metabolite content with differences regarding quantitative contribution of evaluated metab-
olites (b and d). The Y axis of PC1 has an arbitrary unit (a.u.). Experiments revealing similar results in long- and short-term intervention were con-
ducted n = 2 for each.
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response to oxygen changes within minutes. A similar
approach was presented by Pilatus et al. using 10 mm NMR
flow tubes.35 Furthermore, the acquisition time (5–10 min) is
in a comparable time frame as the oxygen quantification time
required using conventional extracellular flux analyzer
(7 min)72 and longer than bionas system (1–4 min)49 and O2k-
FluoRespirometer or lab-on-a-chip system, which determine
decrease of oxygen in real time during long phases of closed
cell chambers.50,51
Individual peak analysis of metabolites directly related to
aerobic energy production via TCA fuel are displayed in
Fig. 6b. As observed in the “stop and go” experiment shown in
Fig. 5a, changes in glycolytic metabolites were observed
(decrease in glucose and pyruvate and increase in lactate
during stopped flow). The relative quantity of produced lactate
is almost equivalent to observed proportion of decrease in pyr-
uvate. A minor quantity of pyruvate might enter tricarboxylic
acid (TCA) cycle for aerobic energy production. Pyruvate and
glutamine are considered to be the main anaplerotic sub-
strates among others.73 A decrease in glutamine was observed
during the prolonged stop periods (Fig. 6) which is consistent
with the observations during reduced flow (Fig. S1c†).
Decreases in glutamine were not detected within shorter flow
rate interruptions of 15 minutes as shown in ESI Fig. S1b.† We
hypothesize the intervention period of 15 minutes are too
short to measure significant degradation of glutamine. The
observed decrease of glutamine goes along increasing evidence
suggesting fibroblasts to degrade glutamine in significant
Fig. 6 (a) Calibration of T1 relaxation time of the CF3 resonance from PFTBA and partial pressure of dissolved oxygen at an operating temperature
of 37 °C. The 19F T1 times were obtained from PFTBA on a carrier embedded in cell free polymerized collagen based scaffold in three independent
experiments. (b) Plot of metabolite concentrations and oxygen content (bottom row) versus time in 20 million fibroblasts measured during perfusion
at 0.2 ml min−1 with medium containing 45% oxygen concentration. During perfusion remaining oxygen concentration of 20–25% was determined.
During stop periods of perfusion (highlighted in red), strong decrease of oxygen concentration was detected. The content of energetically relevant
metabolites during stopped and continued flow from alternately recorded 1H NMR spectra were normalized to their initial values (Rel. to initial) and
also demonstrate cyclic changes. Described experiment revealing similar result was conducted in n = 2.
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amounts for energy production.74 The demonstrated sensitivity
to study glutamine metabolism is of importance as glutamine
is involved in multiple other pathways such as redox homeo-
stasis, macromolecular synthesis, and signalling in cancer
cells.75,76
Glycolytic stress test during constant flow rate. In order to
probe the sensitivity of the bioreactor system upon inhibitor
challenges, a glycolytic stress test during constant perfusion
was performed and monitored by interleaved 19F and 1H
measurements. In Fig. 7 are shown the time courses of oxygen
content and lactate levels during the interventions. In
summary, addition of the respiratory chain inhibitors oligomy-
cin & rotenone led to an increase of measured oxygen concen-
tration in the perfused cell culture sample. Simultaneous upre-
gulation of the lactate production indicates increased glyco-
lytic activity. Subsequent addition of 2-deoxy-glucose inhibited
lactate production completely, while oxygen content remained
constantly high, both according to expectations. Detection of
glycolytic rate and maximum glycolytic capacity provides
important information on cell status and phenotype.77,78
Fig. 7 Glycolytic stress test: culture medium saturated with air contains a partial pressure of 21% oxygen. (a) With a flow rate of 0.2 ml min−1 a
residual amount of approx. 7% oxygen was measured under basal conditions. After the addition of 5 μM oligomycin + 5 μM rotenone no more
oxygen consumption takes place, consequently the oxygen content rises to the value of the admitted amount of oxygen. The oxygen values corres-
pond to the T1 relaxation times of the δ(–CF3) resonance of PFTBA measured by
19F, which were converted into oxygen levels via generated fitting
curve (Fig. 6a). (b) Simultaneous detection of lactate via 1H NMR shows an increase in lactate production after oligomycin + rotenone addition,
which was completely inhibited by the subsequent addition of 5 mM 2-deoxy-glucose. Described experiment revealing similar result was conducted
in n = 2.
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Consequently it allows quantitative analysis of energy pro-
duction of glycolysis and oxidative phosphorylation. Oxygen
consumption experiments in perfused bioreactor systems are
not limited due to finite substrates and can therefore be per-
formed for multiple hours with a high number of sequential
injections into the system thus allowing a high freedom in pro-
tocol design. The strength of presented approach for monitor-
ing cellular metabolism lies in particular in the detection of
highly concentrated metabolites that are strongly changing in
concentration. The presented specific results on fibroblasts are
likely cell type dependent, but the principal method is most
likely also applicable to other cell types. The application of the
demonstrated bioreactor setup on metabolically highly aerobic
cells may require various adaptations: cell number reduction,
increase in perfusion rate or increase in perfused oxygen
content. Adaptation of the bioreactor to different cell types
may be optimized using different extracellular matrices (as
scaffold) and other adapted perfused culture medium. On the
other hand metabolically very active cell lines may be even
better suited for bioreactor studies.
While oxygen content is provided in absolute values, metab-
olite levels are currently reported only in relative quantity.
However, absolute metabolite quantification is possible with
the addition of an external reference and assumptions regard-
ing exact number of cells or the ratio of cells to medium in the
NMR sensitive volume (Fig. 3) of the bioreactor.
Presented experiments demonstrate the feasibility of detect-
ing metabolic and mitochondrial respiration in living cells by
combined in vitro metabolic profiling with 1H and 19F NMR
based oxygen consumption studies. The presented bioreactor
system using a standard NMR probe provides new possibilities
for the simultaneous characterization of metabolic and mito-
chondrial functions of living cultured cells.
Conclusions
In this paper we show the feasibility to measure alternately
and in real-time mitochondrial respiration and metabolic data
combining a commercially available flow tube system with a
standard 5 mm NMR probe. We describe in detail a reproduci-
ble collagen based 3D culture system for fibroblasts and a bio-
reactor setup. Using high cell densities of 5–20 million we
demonstrate the viability of the cells and describe the effect of
the flow rate and cell density on the metabolic activity.
Importantly we show the needed sensitivity to detect substrate
degradation rates of major mitochondrial fuel pathways and
ability to measure rapid O2 and lactate changes as surrogate
marker of oxidative phosphorylation and anaerobic glycolysis.
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